Professor
University of Michigan
Ann Arbor, MI, United States
Anna Suk-Fong Lok, MD, DSc (Hon), FAASLD, AGAF
Dr. Lok graduated from the University of Hong Kong Medical School. She completed her hepatology training at the Royal Free Hospital in London under Dame Sheila Sherlock. She was on the faculty at the University of Hong Kong until she moved to the United States in 1992. She joined the University of Michigan as the Hepatology Program Director in 1995 and stayed in that role until 2024 growing the program from 6 to 19 faculty. She was the Associate Chair for Clinical Research in the Department of Internal Medicine from 2008 to 2016 and Assistant Dean for Clinical Research from 2016 until March 2025. She is currently Professor of Internal Medicine at the University of Michigan.
Dr. Lok’s research focuses on natural history and treatment of hepatitis B and C. Her research also includes liver cancer and metabolic dysfunction associated steatotic liver disease. She has published more than 600 papers including each edition of the American Association for the Study of Liver Diseases (AASLD) guideline on hepatitis B. She was the top 1% most cited scientists in the world for the decade 2002-2012.
Dr. Lok served as Associate Editor of Hepatology in 2001-2006 and Senior Associate Editor of Gastroenterology in 2011-2012 and is currently an Associate Editor of Hepatology Communications. Dr. Lok served as AASLD President in 2017.
Dr. Lok has mentored more than 80 fellows and junior faculty from all over the world, some of her mentees are now Chair of Medicine, Chief of Gastroenterology and Hepatology, and CMOs of hospitals.
Dr. Lok has received numerous awards for mentoring, research and service including awards from the American Gastroenterological Association, the Hepatitis B Foundation, the AASLD, the American Liver Foundation, the Canadian Association for the Study of the Liver, and the European Association for the Study of the Liver. She received an honorary DSc from the University of Hong Kong and a Distinguished Professorship from the University of Michigan. She is a member of the American Association for Physicians and the National Academy of Medicine.
Disclosure(s): Brii Biosciences: Advisor/Consultant; Chroma: Advisor/Consultant; Grifols: Advisor/Consultant; Moderna: Advisor/Consultant; Pfizer, Inc.: Advisor/Consultant; Pioneering: Advisor/Consultant; Precision Biosciences: Advisor/Consultant; Roche Molecular Systems, Inc.: Advisor/Consultant; Virion: Advisor/Consultant; Zenasbio: Advisor/Consultant
165 - Novel Strategies to Diagnose, Monitor, Treat and Prevent Hepatitis B and Hepatitis D
Tuesday, October 21, 2025
1:45 PM - 3:00 PM US ET
Tuesday, October 21, 2025
1:45 PM - 2:10 PM US ET